[1]
Uddin, Z. et al. 2020. EFFECTIVENESS OF COMBINATION THERAPY WITH SOFOSBUVIR AND DACLATASVIR IN HCV INFECTED PATIENTS. Journal of Medical Sciences. 28, 3 (Oct. 2020), 239–243.